Anavex Life Sciences Corp. (AVXL)

NASDAQ: AVXL · Real-Time Price · USD

8.12

-0.43 (-5.03%)

At close: May 13, 2025, 4:00 PM

8.21

+0.09 (1.11%)

Pre-market: May 14, 2025, 8:39 AM EDT

Anavex Life Sciences Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Mar '25 Mar 31, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2015 - 2019
Selling, General & Admin	11.34	11.16	12.16	13.14	9.15	6.09	Upgrade
Research & Development	41.9	39.42	40.88	34.52	28.31	20.62	Upgrade
Operating Expenses	53.24	50.59	53.04	47.66	37.46	26.71	Upgrade
Operating Income	-53.24	-50.59	-53.04	-47.66	-37.46	-26.71	Upgrade
Interest & Investment Income	6.16	7.32	6.52	0.95	0.03	0.18	Upgrade
Currency Exchange Gain (Loss)	-0.14	0.19	-0.04	-0.9	-0.27	0.13	Upgrade
Other Non Operating Income (Expenses)	0.09	0.08	-0.04	-	0.05	0.15	Upgrade
EBT Excluding Unusual Items	-47.14	-43	-46.6	-47.62	-37.64	-26.26	Upgrade
Other Unusual Items	-	-	-0.9	-	-	-	Upgrade
Pretax Income	-47.14	-43	-47.5	-47.62	-37.64	-26.26	Upgrade
Income Tax Expense	-	-	0.01	0.36	0.27	0.02	Upgrade
Net Income	-47.14	-43	-47.51	-47.98	-37.91	-26.28	Upgrade
Net Income to Common	-47.14	-43	-47.51	-47.98	-37.91	-26.28	Upgrade
Shares Outstanding (Basic)	85	83	80	77	70	58	Upgrade
Shares Outstanding (Diluted)	85	83	80	77	70	58	Upgrade
Shares Change (YoY)	3.60%	4.61%	3.74%	10.18%	19.95%	18.99%	Upgrade
EPS (Basic)	-0.56	-0.52	-0.60	-0.62	-0.54	-0.45	Upgrade
EPS (Diluted)	-0.56	-0.52	-0.60	-0.62	-0.54	-0.45	Upgrade
Free Cash Flow	-	-30.81	-27.79	-24.24	-30.38	-21.29	Upgrade
Free Cash Flow Per Share	-	-0.37	-0.35	-0.32	-0.43	-0.37	Upgrade
EBIT	-53.24	-50.59	-53.04	-47.66	-37.46	-26.71	Upgrade

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q